Meta‐analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?

NC Maisel, JC Blodgett, PL Wilbourne… - …, 2013 - Wiley Online Library
Aims Although debates over the efficacy of oral naltrexone and acamprosate in treating
alcohol use disorders tend to focus on their global efficacy relative to placebo or their …

Alcohol use disorders and current pharmacological therapies: the role of GABAA receptors

J Liang, RW Olsen - Acta Pharmacologica Sinica, 2014 - nature.com
Alcohol use disorders (AUD) are defined as alcohol abuse and alcohol dependence, which
create large problems both for society and for the drinkers themselves. To date, no …

A Heck–Matsuda Process for the Synthesis of β‐Arylethenesulfonyl Fluorides: Selectively Addressable Bis‐electrophiles for SuFEx Click Chemistry

HL Qin, Q Zheng, GAL Bare, P Wu… - Angewandte Chemie …, 2016 - Wiley Online Library
A Heck–Matsuda process for the synthesis of the otherwise difficult to access compounds, β‐
arylethenesulfonyl fluorides, is described. Ethenesulfonyl fluoride (ie, vinylsulfonyl fluoride …

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence

HM Pettinati, DW Oslin, KM Kampman… - American Journal of …, 2010 - psychiatryonline.org
Objective Empirical evidence has only weakly supported antidepressant treatment for
patients with co-occurring depression and alcohol dependence. While some studies have …

Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

P Steensland, JA Simms, J Holgate… - Proceedings of the …, 2007 - pnas.org
Alcohol dependence is a disease that impacts millions of individuals worldwide. There has
been some progress with pharmacotherapy for alcohol-dependent individuals; however …

Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders

CA Heidbreder, AH Newman - … of the New York Academy of …, 2010 - Wiley Online Library
Repeated exposure to drugs of abuse produces long‐term molecular and neurochemical
changes that may explain the core features of addiction, such as the compulsive seeking …

Recent advances towards sulfur (VI) fluoride exchange (SuFEx) click chemistry

TA Fattah, A Saeed, F Albericio - Journal of Fluorine Chemistry, 2018 - Elsevier
Abstract The Sulfur (VI) Fluoride Exchange reaction (SuFEx) developed by Sharpless and co-
workers in 2014, is a promising new click reaction that rests on the extraordinary elevated …

How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective

P Clapp, SV Bhave, PL Hoffman - Alcohol Research & Health, 2008 - pmc.ncbi.nlm.nih.gov
The development of alcohol dependence is posited to involve numerous changes in brain
chemistry (ie, neurotransmission) that lead to physiological signs of withdrawal upon …

Naltrexone vs placebo for the treatment of alcohol dependence: a randomized clinical trial

DW Oslin, SH Leong, KG Lynch, W Berrettini… - JAMA …, 2015 - jamanetwork.com
Importance Alcohol use disorder is one of the leading causes of disability worldwide. While
effective pharmacological treatments exist, they are efficacious only in certain individuals …

Reduced drinking in alcohol dependence treatment, what is the evidence?

K Mann, HJ Aubin, K Witkiewitz - European Addiction Research, 2017 - karger.com
Abstinence from alcohol has been the prevailing treatment goal for individuals with alcohol
dependence (AD) within the context of specialty alcohol treatment. Yet, alcohol use has …